Diallyl trisulfide regulates cell apoptosis and invasion in human osteosarcoma U2OS cells through regulating

Pan He1, Zhijun Wang2, Bin Sheng2

  • 1The Department of Traumatic and Osteopathology, Hunan provincial people's hospital, Changsha, Hunan, China. h13487490749@126.com.

Abstract

Insights

Diallyl trisulfide (DATS) effectively inhibits osteosarcoma (OS) cell proliferation and metastasis by inducing apoptosis and regulating key signaling pathways. This natural compound shows promise as a potential therapeutic agent for OS treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Osteosarcoma (OS) is a primary bone malignancy with a high propensity for metastasis.
  • Effective therapeutic strategies for OS, particularly targeting proliferation and metastasis, are urgently needed.
  • Natural compounds are being explored for their potential anticancer properties.

Purpose of the Study:

  • To investigate the effects of Diallyl trisulfide (DATS) on the proliferation and metastasis of human osteosarcoma (OS) U2OS cells.
  • To elucidate the underlying mechanisms of action of DATS in OS.

Main Methods:

  • U2OS cells were treated with varying concentrations of DATS.
  • Cell proliferation was assessed using MTT assays.
  • Apoptosis and cell cycle distribution were analyzed by flow cytometry (FCM).
  • Migration and invasion were evaluated using wound healing and Transwell assays.
  • In vivo efficacy was tested in a mouse OS xenograft model.

Main Results:

  • DATS exhibited a time- and concentration-dependent cytotoxic effect on U2OS cells.
  • DATS induced apoptosis and G0/G1 cell cycle arrest.
  • DATS significantly inhibited cell migration and invasion in vitro.
  • In vivo studies showed reduced tumor volume, weight, and lung metastasis in DATS-treated mice.
  • DATS modulated the expression of key proteins involved in cell survival and metastasis, including the PI3K/AKT/GSK3β pathway.

Conclusions:

  • DATS effectively inhibits osteosarcoma progression by suppressing cell proliferation, migration, and invasion.
  • The anticancer effects of DATS are mediated through the regulation of PI3K/AKT/GSK3β signaling pathways.
  • DATS demonstrates potential as a therapeutic agent for osteosarcoma, either as a standalone treatment or in combination therapy.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.5K